FAD3T(APP/PS1/Tau) from GemPharmatech

Get Pricing

Get Pricing from
GemPharmatech for
FAD3T(APP/PS1/Tau)

Supplier Page

Description

FAD3T is a triple-transgenic Alzheimer's disease model expressing human APP (Swedish), PSEN1 (M146V), and MAPT (P301L). The model develops both amyloid-β plaques and hyperphosphorylated Tau pathology together with neuroinflammation and cognitive impairment at an early age, with spatial memory deficits appearing earlier in females than males. It is suitable for studies of Alzheimer's disease pathogenesis, biomarker development, and preclinical evaluation of therapeutic candidates